Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV

Piekos Brian sold 1,862 Kalvista Pharmaceuticals, Inc. shares (Form 4)

Traded Apr 16 to Apr 17, 2026 · Filed Apr 20, 2026

From Apr 16 to Apr 17, 2026, Piekos Brian (Chief Financial Officer) sold 1,862 Kalvista Pharmaceuticals, Inc. shares at US$20.22 for US$37,650, leaving 18,150 shares. Filed Apr 20, 2026 (Form 4).

Sold
1,862 shares
Price
US$20.22
Value
US$37,650
Holding after
18,150 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 16, 2026Common StockOption exercise6,25020,012Direct
Apr 17, 2026Common StockSale1,862US$20.2218,150Direct

Source

View original at SEC

Related